Biotechnology in healthcare technologies and innovations. Volume 1 /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London :
Academic Press,
2022.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- Biotechnology in Healthcare, Volume 1
- Copyright Page
- Dedication
- Contents
- List of contributors
- About the editor
- Preface
- 1 Overview of healthcare biotechnology
- 1.1 Introduction
- 1.2 Genomics
- 1.2.1 Genetic screening and testing
- 1.2.2 Diagnosis of genetic disorders
- 1.2.2.1 Polymorphism-based molecular makers
- 1.2.2.2 Polymerase chain reaction-based methods
- 1.2.2.3 Array based methods
- 1.2.2.4 Sequencing and its advances for genomics
- 1.2.2.5 Whole exome sequencing and clinical genome exome sequencing for genomic diagnostic
- 1.2.3 Pharmacogenomics and epigenomics
- 1.2.4 Personalized medicine
- 1.3 Transcriptomics
- 1.3.1 Tools of transcriptomics
- 1.3.1.1 Expressed sequence tag
- 1.3.1.2 Serial analysis of gene expression and cap analysis of gene expression
- 1.3.1.3 Microarrays
- 1.3.1.4 RNA-seq
- 1.3.1.5 Real-time polymerase chain reaction
- 1.3.2 Transcriptomics in disease diagnosis
- 1.3.3 Transcriptome profiling in drug discovery
- 1.4 Proteomics
- 1.4.1 Tools and techniques in the proteomics-based study
- 1.4.1.1 Purification of protein
- 1.4.1.2 Analysis of proteomes
- 1.4.1.3 Characterization of proteins
- 1.4.1.4 Sequence analysis
- 1.4.1.5 Quantification of proteomes
- 1.4.1.6 Structural analysis
- 1.4.1.7 Bioinformatics analysis
- 1.4.2 Biomarker discovery
- 1.4.3 Drug development
- 1.5 Metabolomics
- 1.5.1 Tools and techniques in metabolomics study
- 1.5.1.1 NMR spectroscopy
- 1.5.1.1.1 One-Dimensional-NMR
- 1.5.1.1.2 Two-dimensional-NMR
- 1.5.1.2 Mass spectrometry
- 1.5.2 Metabolomics in treatment of cancer, neurological, and psychiatric disorders
- 1.5.2.1 Metabolomics in cancer studies
- 1.5.2.2 Metabolomics in neurological disorders
- 1.5.2.3 Metabolomics in psychiatric disorders
- 1.5.3 Individualized metabolomics
- 1.6 Conclusion
- Acknowledgments
- References
- 2 Three-dimensional printing in healthcare
- 2.1 Introduction
- 2.2 Three-dimensional printing technology (hardware and software)
- 2.3 Materials of three-dimensional printing
- 2.4 Three-dimensional printing in surgical planning and medical education
- 2.5 Three-dimensional printing in oral and maxillofacial surgery
- 2.6 Three-dimensional printing in orthopedics
- 2.7 Three-dimensional printing in neurosurgery
- 2.8 Bioprinting tissue and organ fabrication
- 2.9 Three-dimensional printing in pharmaceutical industry
- 2.10 Future of three-dimensional printing
- 2.10.1 Limitations of three-dimensional printings
- 2.11 Conclusion
- References
- 3 Synthetic biology in healthcare: technologies and applications
- 3.1 Introduction
- 3.1.1 Cell-free systems and applications
- 3.2 Technologies for synthetic DNA, proteins, and organisms
- 3.2.1 Synthetic biology-based Doggybone DNA technology and its uses in vaccines and DNA-based gene therapy products